Latest Agm News

Genetic Signatures has added a new AGM resolution seeking approval to issue up to 340.7 million shares and 129.7 million options under its proposed Microba merger. The all-scrip transaction remains non-binding and subject to further shareholder, court, regulatory and due diligence conditions.

Cycliq’s customer receipts rose 21% in the September quarter, but the cycling technology company ended the period with just $382,000 in cash and less than two quarters of funding on its current burn rate. Its proposed $1.5 million placement remains partly dependent on shareholder approval.

Supply Network is targeting around $50 million of additional revenue in FY2027 after delivering 15.5% sales growth and expanding its Multispares network across Australia and New Zealand. The next phase includes a planned $9 million Penrith branch and further capacity upgrades, although the company has not quantified the earnings return from that investment.

Steadfast Group’s proposed takeover has cleared a key procedural hurdle, with the Supreme Court of New South Wales approving the shareholder meeting and distribution of the Scheme Booklet. An independent expert says the deal is in shareholders’ best interests in the absence of a superior proposal.

Temple & Webster is holding to its FY27 EBITDA target of $33 million to $40 million even as revenue fell 8% in the first months of the year. The online retailer says reduced discounting is depressing sales but improving contribution margins, while AI, private-label products and brand investment move from testing into rollout.

Bhagwan Marine reported $81.3 million in Q1 FY27 revenue, up 32% on the prior corresponding period, as subsea services and Riverside Industrial Sands led a stronger start to the year. Recurring revenue also increased to 64%, while new subsea awards and a Riverside Guardian contract added to the growth pipeline.

Bapcor says its operational reset is beginning to show through, with first-quarter Trade sales up 2.5%, margins improving and net debt falling to $116 million. The recovery remains early, however, with Retail still under pressure and FY27 earnings weighted heavily to the second half.

Cleanaway has reaffirmed FY27 underlying EBIT guidance of $500 million to $530 million as its proposed EQT Infrastructure takeover moves into the approval process. The AGM also disclosed a second strike against the remuneration report, alongside sharply reduced executive incentive outcomes and continued scrutiny of safety and cash conversion.

Magellan Financial Group says its Barrenjoey merger is integrating ahead of schedule, with annual synergies now forecast at $15 million. The group also reported $778 million of pro forma FY26 revenue, while warning that early FY27 trading has been softer in Financial Markets and Investment Management.

Genetic Signatures and Microba Life Sciences have agreed in principle to revise their proposed merger, reducing Microba shareholders’ post-deal ownership from about 67% to 60%. The change improves the position of existing GSS shareholders, but the transaction remains non-binding and subject to multiple approvals.

Sigma Healthcare has entered FY27 with double-digit Chemist Warehouse sales growth, stronger earnings and a merger integration program targeting $100 million in annual synergies by FY29. The next test is whether store expansion and technology consolidation can convert momentum into durable cash returns.

Bega Cheese has entered FY2027 with normalised EBITDA guidance of $240 million to $245 million after delivering a sharp improvement in FY2026 earnings. The company expects a relatively flat first half before stronger growth in the second half, supported by branded products, automation and manufacturing savings.